Matti Jaakko Kesti
Directeur/Membre du Conseil chez Auregen Biotherapeutics SA
Provenance du réseau au premier degré de Matti Jaakko Kesti
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Auregen Biotherapeutics SA
 Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland.
8
| Holding Company | Packaged Software | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matti Jaakko Kesti via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Georgetown University | College/University | Undergraduate Degree | |
| University of Warwick | College/University | Masters Business Admin | |
| University of Portsmouth | College/University | Undergraduate Degree | |
| University of Milan | College/University | Doctorate Degree | |
| BONESUPPORT HOLDING AB | Medical Specialties | Chief Executive Officer | |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bergbahnen Destination GSTAAD AG
 Bergbahnen Destination GSTAAD AG RestaurantsConsumer Services Bergbahnen Destination GSTAAD AG engages in the operation of mountain railways. It manages transport facilities and mountain lodges. The company was founded on May 1, 2003 and is headquartered in Gstaad, Switzerland. | Restaurants | Director/Board Member | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Chairman | |
| Georgetown University School of Medicine | College/University | Doctorate Degree | |
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Executive Officer | |
Bone Support Incentive AB
 Bone Support Incentive AB Real Estate DevelopmentFinance Part of BONESUPPORT HOLDING AB, Bone Support Incentive AB provides real estate services. The company is based in Lund, Sweden. | Real Estate Development | Chairman | |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Pharmaceuticals: Major | Director/Board Member | |
Commave Therapeutics SA
 Commave Therapeutics SA Pharmaceuticals: MajorHealth Technology Commave Therapeutics SA is a Swiss pharmaceutical manufacturing company. The private company is based in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Auregen Biotherapeutics, Inc.
 Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Skylark Bio, Inc.
 Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| ALVOTECH | Biotechnology | Director/Board Member | |
| Stallergenes Canada, Inc. | Director/Board Member | ||
| Amgen Australia Pty Ltd. | Corporate Officer/Principal | ||
| STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 9 |
| Royaume-Uni | 6 |
| Suisse | 4 |
| Suède | 4 |
| Italie | 2 |
Sectorielle
| Health Technology | 15 |
| Consumer Services | 7 |
| Commercial Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 15 |
| Corporate Officer/Principal | 6 |
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
Relations les plus connectées
- Bourse
- Insiders
- Matti Jaakko Kesti
- Connexions Sociétés
